Objective: We recently identified in the mouse bone marrow a B-lymphoid/myeloid B220+ CD11b+ progenitor population. This population is accumulated in the osteopetrotic oc/oc mouse, which suggests that it could be controlled by bone marrow factors whose expression varies in this pathologic bone environment. Among the possible factors, interleukin (IL)-7 is involved in the control of B lymphopoiesis and osteoclastogenesis. Therefore, we hypothesized that IL-7 could regulate the accumulation of the B220+ CD11b+ population in oc/oc mice.
Methods: B220+ CD11b+ cells sorted from oc/oc mice were treated with IL-7 and their phenotype was analyzed by flow cytometry and real-time reverse transcriptase polymerase chain reaction (RT-PCR). In vivo, IL-7 was injected in oc/oc mice, and B220+ CD11b+ and B cells, as well as B-cell proliferation and apoptosis, were analyzed by flow cytometry. The expression of B lymphopoiesis and myelopoiesis markers was analyzed by real-time RT-PCR.
Results: In vitro, IL-7 induced the differentiation of B220+ CD11b+ cells into B lymphocytes through the induction of Pax5 and the inhibition of myeloid markers. In vivo, IL-7 injections in oc/oc mice induced a decrease of the B220+ CD11b+ population and the partial restoration of B-cell population, which was reduced in oc/oc mice. In parallel, upon IL-7 injections, Pax5 expression was induced in B220+ cells and B-cell apoptosis was reduced.
Conclusions: Our results demonstrate that IL-7 injection can partially rescue B lymphopoiesis in oc/oc mice through the engagement of the B220+ CD11b+ population in the B-lymphoid pathway. Therefore, IL-7 delivery could represent a new therapeutic perspective to circumvent the lymphopenia observed in infantile malignant osteopetrosis patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.exphem.2006.04.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases.
J Immunother Cancer
July 2024
Department of Hematology and Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, USA
Article Synopsis
- - TLR9 agonists, particularly nelitolimod, enhance the immune response against liver tumors by promoting the killing of micro-organisms and cancer cells, although their effectiveness is limited by specific immune cell behaviors and drug delivery challenges.
- - A new delivery method called pressure-enabled drug delivery (PEDD) improves the targeting of TLR9 agonists to tumors, leading to increased depletion of suppressive immune cells (MDSCs) and overall immune stimulation, especially when combined with checkpoint inhibitors.
- - In experiments with mice, the system showed promising results when nelitolimod was given directly to the tumor alongside either systemic or subcutaneous administration of immune checkpoint inhibitors, resulting in notable changes in immune cell populations within the tumors.
The complex heterogeneity of immune cell signatures across wasting tissues with C26 and 5-fluorouracil-induced cachexia.
Am J Physiol Cell Physiol
February 2024
Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States.
Immune cell-driven pathways are linked to cancer cachexia. Tumor presence is associated with immune cell infiltration whereas cytotoxic chemotherapies reduce immune cell counts. Despite these paradoxical effects, both cancer and chemotherapy can cause cachexia; however, our understanding of immune responses in the cachexia condition with cancer and chemotherapy is largely unknown.
View Article and Find Full Text PDFHematopoietic and stromal DMP1-Cre labeled cells form a unique niche in the bone marrow.
Sci Rep
December 2023
Center for Regenerative Medicine and Skeletal Development, MC 3705, School of Dental Medicine, UConn Health, 263 Farmington Ave, Farmington, CT, 06030, USA.
Skeletogenesis and hematopoiesis are interdependent. Niches form between cells of both lineages where microenvironmental cues support specific lineage commitment. Because of the complex topography of bone marrow (BM), the identity and function of cells within specialized niches has not been fully elucidated.
View Article and Find Full Text PDFTLR7/TLR8 activation and susceptibility genes synergize to breach gut barrier in a mouse model of lupus.
Front Immunol
July 2023
Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, United States.
Background: Mounting evidence suggests that increased gut permeability, or leaky gut, and the resulting translocation of pathobionts or their metabolites contributes to the pathogenesis of Systemic Lupus Erythematosus. However, the mechanisms underlying the induction of gut leakage remain unclear. In this study, we examined the effect of a treatment with a TLR7/8 agonist in the B6.
View Article and Find Full Text PDFATG-E1 improves particulate matter 10 plus diesel exhaust particles (PMD)-induced airway inflammation by regulating immune responses.
Front Microbiol
April 2023
AtoGen Co., Ltd., Daejeon, Republic of Korea.
Particulate matter (PM) exposure can adversely affect respiratory function. Probiotics can alleviate the inflammatory responses in respiratory diseases. We examined the protective effects of ATG-E1 isolated from the feces of a newborn baby against airway inflammation in a PM plus diesel exhaust particle (DEP) (PMD)-induced airway inflammation model.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!